Summary
Dragonfly Therapeutics , Inc.
Founded in 2016
Description
Dragonfly Therapeutics is a clinical stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel bispecific antibody technology to harness the body's immune system to bring breakthrough treatmen...
Strengths
- Dragonfly Therapeutics , Inc. has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since Dragonfly Therapeutics , Inc. was founded, the company has grown faster than the industry average
- Employees are staying with the company and less likely to churn compared to the rest of the industry
Weaknesses
- Variance of revenue growth is more than the industry average
Annual Revenue
Dragonfly Therapeutics , Inc.'s annual revenue
$8395000
Based on Kona Equity data
-
Revenue per employee
$270806
-
Variance of revenue growth
0.11
-
Annual revenue growth since founding
$1049375
-
Revenue growth rate from first known quarter to current
216.6%
Employee Count
31 employees
-
Employee growth rate from first known quarter to current
214.3%
-
Current employees on Linkedin
75
-
Churned employees
23
-
Churn rate percentage
30.67%
Executives
Maura Mccarthy
Vice President, Corporate Development
m**@dragonflytx.comNicole Kostka
Assistant Controller
n**@dragonflytx.comJinyan Du
Associate Director
j**@dragonflytx.comCory Loder
Director, Facilities Operations
c**@dragonflytx.comLauren Herschelman
Research Associate I
l**@dragonflytx.comNicolai Wagtmann
Chief Scientific Officer
n**@dragonflytx.comJeffrey Ucran
Vice President, Program & Alliance Management
j**@dragonflytx.comShuji Sato
Associate Director, Antibody Discovery
s**@dragonflytx.comEric Lee
Manager, Lab Operations
e**@dragonflytx.comMark Derose
Associate Director, Drug Product
m**@dragonflytx.comTyler Tribou
Research Associate I
t**@dragonflytx.comMichael Naill
Vice President, CMC Technical Operations
m**@dragonflytx.comSamantha Cooper
Program Manager, Research
s**@dragonflytx.comDanielle Huggins
Scientist II
d**@dragonflytx.comJoe Ponte
Vice President Immuno-Oncology
j**@dragonflytx.comJean-Marie Cuillerot
Chief Medical Officer
j**@dragonflytx.comKerry Donahue
Senior Director, Program & Alliance Management
k**@dragonflytx.comZachary Fagiani
Biomolecular Interactions Analyst
z**@dragonflytx.comAnne Deconinck
Senior Director, Corporate Development
a**@dragonflytx.comTapan Maniar
Clinical Development Head
t**@dragonflytx.comYvonne Fang
Manager, Accounting
y**@dragonflytx.comStanton Young
Associate Director, Laboratory Operations & Information Technology
s**@dragonflytx.comAlexey Lugovskoy
Chief Operating Officer
a**@dragonflytx.comJeannette Hasapidis
Vice President, Clinical Operations
j**@dragonflytx.comBrian Fairchild
Senior VP, Legal
b**@dragonflytx.comSean Rossi
Associate Director
s**@dragonflytx.comJarrod Womble
Associate Director, Ad & QC
j**@dragonflytx.comStuart Hicks
Director, Immuno-Oncology
s**@dragonflytx.comG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
- G8 LinkedIn Churn is lower than the industry average.
Location
Unlock unlimited leads
Similar Companies
Tactiva Therapeutics LLC
tactivatherapeutics.com- Founded in 2016
- Location: Buffalo, NY
- Annual Revenue: $4.9M
- Employees: 8
- Tactiva Therapeutics is an immuno-oncology company specializing in potent cancer immunotherapy using a dual T cell receptor approach.
IN8Bio
in8bio.com- Founded in 2016
- Location: New York City, NY
- Annual Revenue: $4.0M
- Employees: 21
- IN8bio is a biopharmaceutical company focused on delivering an innovative T cell immunotherapy for the treatment of cancers.
Geneius
geneius.com- Founded in 2015
- Location: Natick, MA
- Annual Revenue: $6.1M
- Employees: 30
- Geneius is an immuno-oncology company that has developed an innovative autologous, adoptive T cell therapy technology which generates a more robust immune response to cancer compared to current approaches
Pyxis Oncology
pyxisoncology.com- Founded in 2019
- Location: Cambridge, MA
- Annual Revenue: $18.9M
- Employees: 64
- Pyxis Oncology is a biotechnology company that is focused on developing therapeutics for difficult to treat cancers. They are building a portfolio of biologics, including antibody drug conjugates (ADCs) and immunotherapies. Their clinical assets, such ...
Unleash Immuno Oncolytics
unleash.bio- Location: St. Louis, MO
- Annual Revenue: $3.4M
- Employees: 10
- Unleash Immuno Oncolytics is an immuno-oncology company focused on developing novel therapeutics to treat cancer.
Amphivena Therapeutics Inc
amphivena.com- Founded in 2012
- Location: South San Francisco, CA
- Annual Revenue: $7.2M
- Employees: 20
Key Information
- Name: Dragonfly Therapeutics , Inc.
- Category: Pharmaceuticals
- Industry: Corporate Office
- SIC: 80; 283
- NAICS: 541; 5417
See similar companies
-
By City Waltham Small Corporate Office in Waltham Mid-size Corporate Office in Waltham Pharmaceuticals in Waltham Small Pharmaceuticals in Waltham Mid-size Pharmaceuticals in Waltham
-
By State MA Small companies in MA Pharmaceuticals in MA Small Pharmaceuticals in MA Mid-size Pharmaceuticals in MA Small Corporate Office in MA Mid-size Corporate Office in MA
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Corporate Office Small Corporate Office Mid-size Corporate Office Pharmaceuticals and Corporate Office
-
Firmographic data G Score of 6 Founded in 2016 SIC: 80 SIC: 283 NAICS: 541 NAICS: 5417 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
Dragonfly Therapeutics , Inc.'s headquarters are located at 35 Gatehouse Dr. Waltham, MA 02451.
Dragonfly Therapeutics , Inc.'s official website is dragonflytx.com
Dragonfly Therapeutics , Inc.'s annual revenue is $8.4 M.
Dragonfly Therapeutics , Inc.'s SIC: 80; 283
Dragonfly Therapeutics , Inc.'s NAICS: 541; 5417.
Dragonfly Therapeutics , Inc. has 31 employees
Dragonfly Therapeutics , Inc. is in the industry of Pharmaceuticals.
